Zimmer Biomet adds 178 Florida jobs; Medication error in half of surgeries, finds study;

@FierceMedDev: ICYMI: Healthcare, wellness drive Philips growth as it works to shed lighting. Report | Follow @FierceMedDev

@VarunSaxena2: ICYMI: J&J device heads say the new med tech innovation model calls for more external partnerships. Article | Follow @VarunSaxena2

@EmilyWFierce: Stanford scientists reveal artificial skin device for prosthetics. Story | Follow @EmilyWFierce

> Zimmer Biomet ($ZBH) reportedly will add 178 jobs at its dental implant facility in Palm Beach Gardens, FL. The move was expected as part of a post-merger restructuring. Story

> A study of more than 275 operations at Massachusetts General Hospital found that one out of two surgeries had medication errors with one-third of these resulting in adverse events or patient harm. More

> York, PA-based hospital WellSpan York has started notifying about 1,300 open-heart surgery patients who were exposed to aerosolized bacteria via a body heater-cooler devices during surgery. The FDA issued a warning about this earlier this month. More

> The Wall Street Journal features a Q&A with uBiome co-founder and CEO Jessica Richman on why consumers would want to monitor their microbiome. Story

Biotech News

@FierceBiotech: GlaxoSmithKline's cardio R&D group records another big PhIII flop. News | Follow @FierceBiotech

@JohnCFierce: Kite Pharma taps Mitch Gold's upstart Alpine for T-cell immuno-tech. Article | Follow @JohnCFierce

> After a big-money Allergan deal, Taris returns with a $32M round and a new pipeline. Item

> After Eli Lilly flop, Merck adds a futility challenge to huge PhIII anacetrapib study. Article

Pharma News

@FiercePharma: Roche's O'Day says portfolio firing well in international markets, Japan a star. FiercePharmaAsia story | Follow @FiercePharma

@CarlyHFierce: "I've heard two CEOs use the word 'bold' in the last couple months..." - DB's Gilbert insinuating a $PFE $AGN tie-up. | Follow @CarlyHFierce

> Novartis shells out $390M to settle specialty pharmacy kickback claims. Report

> Bristol-Myers rides Opdivo, hep C sales to Q3 beat. More

> Senator slaps Valeant for sparse response on pricing decisions. Article

Pharma Manufacturing News

> U.K. cites the GSK China plant that was damaged by explosions. News

> Sun recalls 1M-plus boxes of generic Claritin made at Ohm Labs. Report

> Boehringer's Roxane plant mixes up APIs for blood pressure med. Story

> Lawsuit challenges Cipla's buyout of InvaGen. Item

> Spain's Grifols opening $100M warehouse, labeling operation in Dublin. Article

Drug Delivery News

> MIT: Ultrasound gives GI drugs a quicker delivery with less discomfort. Story

> 'Screen door' through blood-brain barrier gives Parkinson's drugs a way in. More

> Capsugel launches coating-free enteric protection delivery platform for oral meds. News

> FDA approval of Endo and BDSI's painkiller a win for buccal drug delivery. Item

> Flowonix to develop drug delivery implant for Cerebral's neurological candidates. Report

Pharma Asia News

> Tata Institute says paper shows 'early success' in malaria vaccine. More

> Indian health officials slam Lancet editor's comments. Article

> Lilly takes Q3 hits in emerging markets on FX, but Japan shows bright spots. Story

> Roche's O'Day says portfolio firing well in international markets, Japan a star. More

> China's ZAI Lab goes novel in drug development, makes key hire. Report